We just released our eigth issue of the NoxLetter. It is full of interesting articles and valuable material.
Reykjavik, July 5, 2018 –Nox Medical, a leading sleep diagnostic medical device company and innovator has achieved another major milestone in its litigation with Natus Neurology. On June 5, 2018, Judge Richard G. Andrews of the U.S. District Court for the District of Delaware issued a permanent injunction against Natus and anyone acting in active concert or participation with it from making, using, selling or offering to sell the Natus XactTrace Single Use Pre-Sized RIP Belt that Natus admitted infringes Nox’s patent in the United States. Natus is also prohibited from importing the infringing belt into the United States. A copy of the permanent injunction can be found here below.
Reykjavik, May 18, 2018 –Nox Medical, a leading sleep diagnostic medical device company and innovator has achieved a major success in its case in the U.S. District Court for the District of Delaware alleging that Natus Neurology willfully infringed Nox Medical’s U.S. Patent No. 9,059,532 covering the biometric connector on its disposable RIP belts.
Nox Medical is looking for a new Chief Financial Officer to join the team.
Please take a look at the position here.
We are proud to introduce a new distributor into the Nox distribution network. In cooperation with CHANJOU CO., LTD (head office located in New Taipei City) we have launched our Nox products at the Taiwanese Sleep Society Meeting 2018 in late March.
Reykjavik, April 3rd, 2018 –Nox Medical, a leading sleep diagnostic medical device company and innovator has achieved a major success in EPO opposition proceedings initiated by Natus concerning one of Nox Medical’s key patents, EP 2 584 962 B1, covering the biometric connector on its disposable RIP belts. The European Patent Office (EPO) has concluded that Nox Medical’s European patent on the Nox RIP Belts is valid as amended in the opposition proceedings. Nox Medical is confident that its patent will also survive the appeal proceedings. In the United States, the patent infringement case against Natus based on a U.S. patent belonging to the same patent family as the above-mentioned EP patent is set for trial beginning April 30, 2018.
With contributions from our in-house experts, our newsletter focuses on what we are working on, new releases, insightful news and keeping you informed of our upcoming events and activities.
If you find this issue of The NoxLetter interesting, feel free to share it with your friends and colleagues.
Browse the issue here.
We are happy to announce that Nox Medical and Brojaw have signed a partnership agreement for distributing Nox sleep systems in Taiwan. Registration is now being finalized and with this agreement, Brojaw receives full responsibility of promoting, selling and providing customer service for Nox T3 and Nox A1 in the country.